Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: J Clin Virol. 2009 Dec 16;47(2):196. doi: 10.1016/j.jcv.2009.11.019

Merkel Cell Polyomavirus is not detected in Mesotheliomas

Kishor Bhatia 1, Rama Modali 2, James J Goedert 1,*
PMCID: PMC2818524  NIHMSID: NIHMS160883  PMID: 20006539

Abstract

Background

Merkel cell polyomavirus (MCPyV) is the first polyoma virus consistently linked to the etiology of a human cancer. Serological studies indicate that the virus is commonly acquired in childhood, with seroprevalence reaching 50% or higher among young adults. The modes of MCPyV transmission are still unclear, but it has been identified in respiratory tract samples. Given its respiratory tropism, we examined whether MCPyV could be detected in mesothelioma tissue, a malignancy induced in animal models by another polyomavirus, SV40.

Objective

To determine if MCPyV DNA can be detected in mesothelioma.

Study design

DNA was extracted from 45 fresh-frozen mesothelioma samples. PCR was used to detect and quantify the abundance of MCPyV DNA, and a human control gene, in duplicates of the tissues. DNA from a sequence verified MCC tumor was used as a positive control.

Results

The human control gene was detected at high levels in all but three mesothelioma tissues. MCPyV DNA was detected in only one mesothelioma, and the level of viral DNA was very low.

Conclusions

These results are inconsistent with the hypothesis that MCPyV is etiologically linked to meosthelioma.

Keywords: Mesothelioma, polyomavirus, Merkel cell carcinoma and MCPyV

1. Background

Malignant mesotheliomas are most often associated with asbestos exposure 1, 2. However, the majority of individuals exposed to asbestos do not develop this malignancy 3, 4. Moreover, of the 2000–3000 cases of mesotheliomas reported annually in the US, as many as 400–600 occur in persons who are apparently asbestos naïve, suggesting the possibility of other etiological factors. The likelihood that additional causative or risk factors might exist is also supported by the smaller than predicted decline in the incidence of mesothelioma following asbestos control measures 5.

Among agents of potential etiological interest in mesothelioma, the SV40 polyomavirus has featured prominently. Several reports support a role for SV40 in mesothelioma, while many other reports have questioned or even negated a role for this virus 6, 7, 8, 9. A biological rationale for a role for SV40 is that it efficiently induces transformation of mesothelial cells and that asbestos and transforming proteins of the virus synergize to enhance proliferation and survival and to counteract apoptosis of mesothelial cells. The oncogenic effects of SV40 are attributed to up-regulation of oncogenic pathways, including activator protein-1 and NF-κB transcription factors and the prosurvival Akt pathway in human and murine mesotheliomas 10, 11, 12, 13, 14, 15.

In contrast, epidemiological studies have generally failed to support a role for SV40 16, 17. Perhaps the dichotomy between the positive mechanistic laboratory models of viral induced mesothelioma and the negative epidemiological studies relates to a different or unidentified human virus with similar potential oncogenic attributes.

The Merkel cell polyomavirus (MCPyV) was recently discovered and tightly linked to a rare neuroendocrine cancer, Merkel cell carcinoma (MCC) 18. Like SV40, this virus is dependent upon its Large T (LT) antigen to affect transformation19. Conclusive data from several reports support an etiological link between MCPyV and MCC 20, 21, 22, 23. These data support the concept that, unlike the classical human polyomaviruses (JC, BK, KI and WU), MCPyV is the first human polyomavirus with clear oncogenic potential. Like JC, BK, KI and WU, MCPyV is quite prevalent. Seroepidemiology data indicate that humans are commonly exposed to MCPyV during childhood, with seroprevalence reaching 50% or more by early adulthood. In one report, the virus was detected in skin swabs from 62% of healthy adults 24, 25, 26. The route of MCPyV transmission is not yet established, but MCPyV has been detected in respiratory tract specimens 27, 28, 29. Higher levels of the virus have been reported in the upper aerodigestive tract, digestive system, and saliva, with lower levels in lung and genitourinary system samples 30. MCPyV was not detected in 48 lung tumors of neuroendocrine subtypes 31, 32.

2. Objective

The overall objective of this study was to test the hypothesis that the human carcinogenic polyomavirus MCPyV might contribute to malignant mesothelioma.

3. Study design

3.1 Tissues

We assembled 45 fresh frozen independent mesothelioma samples from The National Mesothelioma Virtual Bank (NMVB). All samples were histologically confirmed. As control material, we obtained DNA from 20 peripheral blood lymphocyte specimens from an unrelated set of individuals. DNA from 3 MCC tumors previously found to contain the virus with an abundance of > 1 MCPyV genome per tumor cell were used as positive controls. The National Institutes of Health, Office of Human Subjects Research approved the use of these de-identified specimens.

3.2 DNA extraction and PCR

DNA from frozen tissue samples was extracted using the Quick DNA extraction kit (Bioserve Biotechnologies Ltd, Laurel, MD). Details of the real time PCR assay used to detect and quantify MCPyV has been described previously 20. In brief, the MCPyV forward primer was GCAAAAAAACTGTCTGACGTGG and the reverse primer was CCACCAGTCAAAACTTTCCCA. The probe sequence was TATCAGTGCTTTATTCTTTGGTTTGGATTTCCTCCT. Each reaction contained genomic DNA in 10µl, 1x TaqMan™ Master Mix, dual-labeled probe (100nM each), and PCR primers (900nM each). Amplification was carried out at 50°C for 15 minutes and 95°C for 10 minutes, followed by 50 cycles of 95°C for 15 seconds and 60°C for 1 minute. Viral quantification was estimated by normalization to the concentration of each tissue’s human DNA by using a probe to detect the single copy human gene RNase P. All MCPyV and RNaseP reactions were performed in duplex, with means used for quantification. Data were analyzed by SDS software developed by Applied BioSystems, Foster City, CA.

4. Results

Forty two of the 45 samples and all 20 PBL samples contained amplifiable human DNA and yielded ample product when tested for cellular control gene (RNase P). None of PBL DNAs yielded a MCPyV amplicon. In one and only one of the duplex runs, one of the 42 mesotheliomas was positive for MCPyV, and estimated viral abundance in this tissue was low. Relative amount of viral DNA present in this mesothelioma was calculated as less than 150 MCPyV copies per million cells.

5. Discussion

Various laboratory studies indicate that early gene products of a polyomavirus713 such as SV40 can induce mesothelioma in animal models. Human epidemiological data, however, have failed to support a link directly with SV408,9,13. The recent discovery of a new polyomavirus, MCPyV, in a human cancer suggested that the discrepancy between the epidemiology studies and the laboratory models might be a result of a different virus with functional similarities to SV40. The long latent period for development of mesothelioma and the small proportion of asbestos exposed individuals who develop this malignancy both indicate the possibility of additional exogenous or endogenous factors3. It is possible that exposure to both asbestos and a virus is necessary for development of mesothelioma.

There is growing molecular pathology evidence that MCPyV infection can be oncogenic and that the oncogenicty of this virus, like that of SV40, is linked to early gene products23. MCPyV has been detected in multiple human tissues 34. To test if there is a direct association between MCPyV and mesothelioma we screened by quantitative PCR analyses a panel of high-quality mesothelioma samples for presence of MCPyV. Our data do not support the hypothesis that MCPyV is directly associated with mesothelioma. Given that some MCC cases have had detectable MCPyV antibodies despite the inability to detect the viral genome in their tumors 24, MCPyV serological studies of mesothelioma cases and appropriate controls would be useful. Nonetheless, our findings strongly suggest that MCPyV, the only human polyomavirus with known carcinogenic potential, is not etiologically linked to mesothelioma. The finding of viral genome at very low levels in 1/42 samples tested is similar to the prevalence and levels of MCPyV DNA in various non-tumor samples including nasopharyngeal aspirates and bronchoalveolar lavage.28,29 These might represent infected bystander or other normal cells in the tumor milieu. If a polyomavirus is indeed linked to human mesothelioma, it probably is not MCPyV.

Acknowledgements

The specimens for this study were kindly provided by The National Mesothelioma Virtual Bank (NMVB) University of Pittsburgh, supported by a grant from the National Institute of Occupational Health and Safety of the Centers for Disease Control and Prevention

Abbreviations

MCPyV

Merkel cell polyomavirus

MCC

Merkel Cell Carcinoma

LT

Large T antigen

FFPE

formalin-fixed, paraffin-embedded

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of Interest: The authors have no conflicts of interest to declare.

References

  • 1.Mossman BT, Kamp DW, Weitzman SA. Mechanisms of carcinogenesis and clinical features of asbestos –associated cancers. Cancer Invest. 1996;14:466–480. doi: 10.3109/07357909609018904. [DOI] [PubMed] [Google Scholar]
  • 2.LaDou J. The asbestos cancer epidemic. Environ Health Perspect. 2004;112:285–290. doi: 10.1289/ehp.6704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mossman B, Bignon J, Corn M, Seaton A, Gee J. Asbestos: scientific developments and implications for public policy. Science. 1990;247:294–301. doi: 10.1126/science.2153315. [DOI] [PubMed] [Google Scholar]
  • 4.Sluis-Kremer GK. Asbestos disease at low exposures after long residence times. Ann NY Acad Sci. 1991;643:182–193. doi: 10.1111/j.1749-6632.1991.tb24461.x. [DOI] [PubMed] [Google Scholar]
  • 5.Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009;39:576–588. doi: 10.1080/10408440903044928. [DOI] [PubMed] [Google Scholar]
  • 6.Weiner SJ, Neragi-Miandoab S. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J Cancer Res Clin Oncol. 2009;135:15–27. doi: 10.1007/s00432-008-0444-9. [DOI] [PubMed] [Google Scholar]
  • 7.Carbone M, Kratzke RA, Testa JR. The pathogenesis of Mesothelioma. Semin in Oncology. 2002;29:2–17. doi: 10.1053/sonc.2002.30227. [DOI] [PubMed] [Google Scholar]
  • 8.Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false positive PCR results owing to the presence of SV40 sequences in common laboratory plasmids. Lancet. 2004;364:1157–1166. doi: 10.1016/S0140-6736(04)17102-X. [DOI] [PubMed] [Google Scholar]
  • 9.Ziegler A, Seemayer CA, Hinterberger M, Vogt P, Bigosch C, Gautschi O, Tornillo L, Betticher DC, Moch H, Stahel RA. Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung Cancer. 2007;57:282–291. doi: 10.1016/j.lungcan.2007.03.025. [DOI] [PubMed] [Google Scholar]
  • 10.Bocchetta M, Di Resta I, Powers A, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A. 2000;97:10214–10219. doi: 10.1073/pnas.170207097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kroczynska B, Cutrone R, Bocchetta M, et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A. 2006;103:14128–14133. doi: 10.1073/pnas.0604544103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Robinson C, van Bruggen I, Segal A, et al. A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. Cancer Res. 2006;66:10786–10794. doi: 10.1158/0008-5472.CAN-05-4668. [DOI] [PubMed] [Google Scholar]
  • 13.Pietruska JR, Kane AB. SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells. Cancer Res. 2007;67:3637–3645. doi: 10.1158/0008-5472.CAN-05-3727. [DOI] [PubMed] [Google Scholar]
  • 14.Carbone M, Pass HI. Evolving aspects of mesothelioma carcinogenesis: SV40 and genetic predisposition. J. Thorac Oncol. 2006;1:169–171. [PubMed] [Google Scholar]
  • 15.Pershouse MA, Heivly S, Girtsman T. Inhal Toxicol. The role of SV40 in malignant mesothelioma and other human malignancies. 2006;18:995–1000. doi: 10.1080/08958370600835377. [DOI] [PubMed] [Google Scholar]
  • 16.Shah KV. SV 40 and human cancer: A review of recent data. Int J Cancer. 2007;120:215–223. doi: 10.1002/ijc.22425. [DOI] [PubMed] [Google Scholar]
  • 17.Leithner K, Leithner A, Clar H, Weinhaeusel A, Radl R, Krippl P, Rehak P, Windhager R, Haas OA, Olschewski H. Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40. Orphanet J Rare Dis. 2006;1:44. doi: 10.1186/1750-1172-1-44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Feng H, Shuda M, Chang Y, Moore PS. Clonal Integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–1100. doi: 10.1126/science.1152586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernández-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer. 2009;125:1243–1249. doi: 10.1002/ijc.24510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW. Merkel cell carcinoma subgroups by merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer. 2009 Jun 23; doi: 10.1002/ijc.24676. [Epub ahead of print] PMID 19551862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Becker JC, Houben R, Ugurel S, Trefzer U, Pföhler C, Schrama D. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol. 2009;129:248–250. doi: 10.1038/jid.2008.198. [DOI] [PubMed] [Google Scholar]
  • 22.Kassem A, Schöpflin A, Diaz C, Weyers W, Stickeler E, Werner M, Zur Hausen A. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 2008;68:5009–5013. doi: 10.1158/0008-5472.CAN-08-0949. [DOI] [PubMed] [Google Scholar]
  • 23.Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Nat. Acad. Sci (USA) 2008;105:16272–16277. doi: 10.1073/pnas.0806526105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009 Sep;5(9):e1000578. doi: 10.1371/journal.ppat.1000578. Epub 2009 Sep 11. PMID: 19750217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Carter JJ, Paulson KG, Wipf GC, Miranda D, Madeleine MM, Johnson LG, Lemos BD, Lee S, Warcola AH, Iyer JG, Nghiem P, Galloway DA. Association of Merkel cell polyoma virus specific antibodies with Merkel Cell Carcinoma. Jour Natl Can Inst. 2009 Sep 23; doi: 10.1093/jnci/djp332. [Epub ahead of print]PMID: 19776382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wieland U, Mauch C, Kreuter A, Krieg T, Pfister H. Merkel cell polyomavirus DNA in persons without merkel cell carcinoma. Emerg Infect Dis. 2009;15:1496–1498. doi: 10.3201/eid1509.081575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kantola K, Sadeghi M, Lahtinen A, Koskenvuo M, Aaltonen LM, Möttönen M, Rahiala J, Saarinen-Pihkala U, Riikonen P, Jartti T, Ruuskanen O, Söderlund-Venermo M, Hedman K. Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J. Clin Virol. 2009;45:292–295. doi: 10.1016/j.jcv.2009.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Goh S, Lindau C, Tiveljung-Lindell A, Allander T. Merkel cell polyomavirus in respiratory tract secretions. Emerg Infect Dis. 2009;15:489–491. doi: 10.3201/eid1503.081206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bialasiewicz S, Lambert SB, Whiley DM, Nissen MD, Sloots TP. Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg Infect Dis. 2009;15:492–494. doi: 10.3201/eid1503.081067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wetzels CT, Hoefnagel JG, Bakkers JM, Dijkman HB, Blokx WA, Melchers WJ. Ultra structural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung. PLoS One. 2009;4(3):e4958. doi: 10.1371/journal.pone.0004958. Epub 2009 Mar 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Busam KJ, Jungbluth AA, Rekthman N, Coit D, Pulitzer M, Bini J, Arora R, Hanson NC, Tassello JA, Frosina D, Moore P, Chang Y. Am J Surg Pathol. 2009;33:1378–1385. doi: 10.1097/PAS.0b013e3181aa30a5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Duncavage EJ, Le BM, Wang D, Pfeifer JD. Merkel Cell Polyomavirus: A Specific Marker for Merkel Cell Carcinoma in Histologically Similar Tumors. Am J Surg Pathol. 2009 doi: 10.1097/PAS.0b013e3181ba7b73. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 33.Loyo M, Guerrero-Preston R, Brait M, Hoque M, Chuang A, Kim M, Sharma R, Liégeois N, Koch W, Califano J, Westra W, Sidransky D. Quantitative detection of merkel cell virus in human tissues and possible mode of transmission. Int J Cancer. 2009 Jul 8; doi: 10.1002/ijc.24737. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES